Thymosin beta-4 Terminated Phase 2 Trials for Diabetes Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00598871A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds